Peter Pelka

Peter Pelka is a seasoned professional in clinical operations with extensive experience in leadership roles at prominent biotechnology and pharmaceutical companies. Currently serving as Director, Clinical Operations Portfolio Lead at Bristol Myers Squibb since June 2020, Peter has previously held similar positions at Asana BioSciences, LLC, Origin, Inc., KBP BioSciences, and Galenus Med GmbH. Peter's educational background includes a Master's degree in Management Studies from Boston University and a certification as a Six Sigma Lean Professional from the Management and Strategy Institute.